Aap Implantate AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
aap Implantate AG issues FY 2014 Q2 outlook; reaffirms FY 2014 outlook
aap Implantate AG:Expects sales for the second quarter of FY 2014 to be between 7.6 million and 8.2 million euros(Q2 2013 (excl. EMCM): 6.6 million euros).Expects EBITDA for the second quarter of FY 2014 to be between 1.0 million and 1.5 million euros (Q2 2013 (excl. EMCM): 0.2 million euros).Reaffirms the sales and EBITDA outlook for the full year of 2014 with sales of 35 million euros and an EBITDA of between 5 million and 6 million euros.
Latest Developments for Aap Implantate AG
- aap Implantate AG issues FY 2014 Q3 outlook and reaffirms FY 2014 outlook
- aap Implantate AG completes spin off of its non-core business dental
- aap Implantate AG announces Bruke Seyoum Alemu as company's new Chairman of Management Board and Chief Executive Officer
- aap Implantate AG gives Q1 2014 sales and EBITDA outlook; not to pay FY 2013 dividend
- Share this
- Digg this